The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Specific receptor for the opioid peptide dynorphin: structure--activity relationships.
Open accessAbstract
The structural features responsible for the high potency and opiate receptor specificity of the opioid peptide dynorphin in the guinea pig ileum myenteric plexus were examined. Successive removal of COOH-terminal amino acids from dynorphin-(1--13) demonstrated important contributions of lysine-13, lysine-11, and arginine-7 to the potency. Removal of the NH2-terminal tyrosine abolished the biologic activity. Several other structural modifications were shown to affect potency: substitution of D-alanine for glycine-2 reduced the potencies of dynorphin-(1--13) amide, -(1--11), and -(1--10); and methyl esterification of the COOH terminus enhanced the potencies of dynorphin-(1--12), -(1--10), -(1--9), -(1--8), and -(1--7). Within the dynorphin sequence, lysine-11 and arginine-7 were found to be important for selectivity of interaction with the dynorphin receptor, which is distinguishable from the mu receptor in this tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
Phosphorylation-Dephosphorylation of Enzymes
Krebs, E. G., & Beavo, J. A. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.004423 · Cited by 2,205
Dynorphin-(1-13), an extraordinarily potent opioid peptide.
Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., & Hood, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6666 · Cited by 882
[D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide Analgesic
Pert, C. B., Pert, A., Chang, J.-K., & Fong, B. T. (1976) · Science · doi:10.1126/science.968485 · Cited by 469
HUGHES, J., KOSTERLITZ, H. W., & LESLIE, F. M. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07373.x · Cited by 403
ACTH: a short introductory review
Schwyzer, R. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41843.x · Cited by 394
Structure-Activity Relationships of Enkephalin-Like Peptides
Morley, J. S. (1980) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.20.040180.000501 · Cited by 280
α-Neo-endorphin: A “big” leu-enkephalin with potent opiate activity from porcine hypothalami
Kangawa, K., Matsuo, H., & Igarashi, M. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)90394-2 · Cited by 227
Morphine‐tolerant longitudinal muscle strip from guinea‐pig ileum
Goldstein, A., & Schulz, R. W. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08254.x · Cited by 155
Self-citationDemonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus
Chavkin, C., & D, A. G. M. (1981) · Nature · doi:10.1038/291591a0 · Cited by 148
Self-citation
Cited by
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
Meunier, J.-C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.-L., Guillemot, J.-C., Ferrara, P., Monsarrat, B., et al. (1995) · Nature · doi:10.1038/377532a0 · Cited by 1,912
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
Self-citationStructural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N., Sanborn, A. L., Kato, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 885
Structure of the human κ-opioid receptor in complex with JDTic
Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X.-P., Carroll, F. I., et al. (2012) · Nature · doi:10.1038/nature10939 · Cited by 879
Structure of the δ-opioid receptor bound to naltrindole
Granier, S., Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Weis, W. I., & Kobilka, B. K. (2012) · Nature · doi:10.1038/nature11111 · Cited by 667
Distribution of dynorphin and enkephalin peptides in the rat brain
Fallon, J. H., & Leslie, F. M. (1986) · Journal of Comparative Neurology · doi:10.1002/cne.902490302 · Cited by 526
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Morley, J. E., Levine, A. S., Yim, G. K., & Lowy, M. T. (1983) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(83)90020-9 · Cited by 451
Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor
Corbett, A. D., Paterson, S. J., McKnight, A. T., Magnan, J., & Kosterlitz, H. W. (1982) · Nature · doi:10.1038/299079a0 · Cited by 447
Cloning and pharmacological characterization of a rat kappa opioid receptor.
Meng, F., Xie, G. X., Thompson, R. C., Mansour, A., Goldstein, A., Watson, S. J., & Akil, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9954 · Cited by 426
Self-citationGoldstein, A., Fischli, W., Lowney, L. I., Hunkapiller, M., & Hood, L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7219 · Cited by 399
Self-citationNociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
Meunier, J.-C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01411-8 · Cited by 388
Membrane lipid phase as catalyst for peptide-receptor interactions.
Sargent, D. F., & Schwyzer, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5774 · Cited by 377
Opioid Receptors and their Ligands
Janecka, A., Fichna, J., & Janecki, T. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043451618 · Cited by 311
30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Schwarzer, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.006 · Cited by 289
Mansour, A., Hoversten, M. T., Taylor, L. P., Watson, S. J., & Akil, H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00928-j · Cited by 267
Dynorphin and its role in alcohol use disorder
Karkhanis, A. N., & Al-Hasani, R. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146742 · Cited by 47
“Dynorphin fragments, described as natural fragments, such as Dynorphin a (1–8), do not have the C-terminal lysines and as a result have lower KOR potency and selectivity (Chavkin and Goldstein, 1981; James and Goldstein, 1984).”
Background
Metadata
- Authors
- Chavkin, C., & Goldstein, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1981-10
- Volume
- 78
- Issue
- 10
- Pages
- 6543-6547
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2074599713
- Cited by
- 423
- References
- 17
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.